ArticleJournal of biomedical science2024

Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections.

Daria V Vasina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.